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Abstract
 Infection of implants by microbial biofilm is chiefly caused by Staphylococci, Pseudomonas and 
Candida species. The growth of microbes by forming biofilms offers them protection from 
antibiotics, drugs and host defense mechanisms. The eradication of biofilms from implants 
and medical devices is difficult because of the protection by the biofilm forming pathogenic 
microbes. Hence, researches are focused on development of antibiofilm materials, which are 
basically constituted of antimicrobial substances or antimicrobial coatings. Nanomaterial-
based coatings offer a promising solution in this regard. Quantum dots (QDs) are the group 
of semiconductor nanoparticles with high photoluminescent properties compared to con-
ventional organic fluorophores. Thus, drug-conjugated QDs can be a promising alternative 
for biofilm treatment, and these can serve as excellent alternatives for the mitigation of recal-
citrant biomaterial-associated infections caused by resistant strains. Furthermore, their use 
as antibiofilm coating would avoid the dispersion of antimicrobial agents in the surround-
ing cells and tissues, thereby minimizing the risks of developing microbial resistivity.
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1. Introduction
Quantum dots (QDs) represent a class of colloidal semiconductor nanocrystals having 
fluorescent properties that absorb photons at a particular (lower) wavelength and emit at 
a higher wavelength. These QDs are basically composed of a core and corona layer. The 
photoluminescence emission wavelength of QDs is directly proportional to its size. The 
core of the QDs may contain one or more heavy elements such as cadmium, selenium, 
zinc or tellurium. QDs possess significant superiority over the conventional fluorophores 
© 2018 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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in terms of physicochemical and fluorescent properties. The distinguishable fluorescent 
properties, smaller size, photostability, resistivity to metabolic degradation and capability 
of conjugation to ligands/biomolecules make QDs a superior choice for biological applica-
tions compared to conventional fluorophores.
In the last three decades, several microbes (fungi, yeast and bacteria) have emerged as major 
human pathogens and have been responsible for causing life threatening diseases especially 
in immunecompromised individuals and patients with serious medical issues [1]. The wide-
spread and prolonged use of antifungal agents and drugs for treating the infection caused 
by the pathogens has resulted in increasing incidences of multidrug resistance (MDR). 
Additionally, several mutant strains have developed that show high resistance to the antifun-
gal drugs being used [1]. For example, Candida albicans, a dimorphic opportunistic pathogen, 
occurs as a normal commensal in humans but becomes pathogenic in immunecompromised 
individuals. The azole resistive clinical isolates of C. albicans result in cross-resistance to several 
unrelated drugs and this arises because of the phenomenon of multidrug resistance (MDR) [2, 
3]. Similarly, Pseudomonas aeruginosa and Staphylococcus aureus are the two most pathogenic 
bacteria known to cause severe infection and biofilm formation [4]. Several mechanisms are 
responsible for development of MDR, some of which involve an overexpression of drug efflux 
pumps encoding genes such as CDR1 and CDR2 belonging to ATP-binding cassette [2, 5, 6]; 
overexpression of the drug and MDR1 belonging to the major facilitator superfamily trans-
porters [3, 6] and overexpression of mutations in ERG11 and encoding the target enzyme of 
azoles, lanosterol 14α-demethylase [7]. Hence, microbial infection has become a major prob-
lem with concerns focusing on those that have become resistant to antibiotics. Around 2 mil-
lion people are affected annually with antibiotic-resistant bacteria of which approximately 
23,000 people die as per the studies of U.S. Center for Disease Control and Prevention [8].
Microbial communities adhere to a solid surface especially in surface/water interference 
forming biofilms [9]. Microbes attach to the surface by means of extracellular polymeric 
substances (EPS), and this acts as their survival means against harsh environmental condi-
tions. Biofilm formation is however associated with surface deterioration and corrosion. In 
addition, pathogenic microbes form biofilms on medical devices and implants, and this has 
become a great concern in the arena of healthcare. Biofilm also enhances microbial activity 
and provides protection against harsh environmental conditions such as drugs, antibiotics 
and common sanitizers. Because of the emerging conditions of MDR, there is a demand for 
developing new drugs, antimicrobial agents and modifiers capable of inhibiting microbial 
growth and biofilm formation. With the necessity of developing antimicrobial agents with 
diverse functionality and ability to kill both strains of bacteria, nanomaterials have been 
widely investigated in this regard. Silver nanoparticles [10], copper oxide nanoparticles 
[11–13], metal oxide nanoparticles [12, 13] and even carbon nanomaterials [14] have been 
reported for their excellent antimicrobial efficiency. Among these, silver nanoparticles have 
been extensively used as antimicrobial and antibiofilm agents due to their broad spectrum 
antimicrobial activity, multiple cellular targets and minimum host toxicity. However, high 
concentration of silver is toxic to humans and its persistent use causes argyrosis and argia 
[15, 16]. Hence, the demand is for exploring novel nanomaterials with effective antimicrobial 
and antibiofilm properties along with biocompatibility. Therefore, the requirement must be 
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targeted towards exploring novel biocompatible nanomaterials with effective antibiofilm 
and optical properties. QDs can be suitable alternatives because of their intriguing opti-
cal, fluorescence, high quantum yield, photostability and easy conjugation efficiency. QDs 
easily attach to microbial surface because of their small size and their dispersion stability 
is basically governed by colloidal theory [17]. These are excellent candidates in biomedi-
cal applications such as imaging, diagnosis and sensing and drug discovery. Developing 
QDs-based nanocomposites as coating materials on implants and catheters can thus combat 
pathogenic invasion and biofilm formation. QDs could be engineered with coating agents 
and conjugated with bioactive ligands or biorecognition elements for targeted treatment, 
biofilm visualization, and inhibition.
2. Biofilm formation, its mechanism and transmission
Biofilm can be defined as microbial cells enclosed in an exopolysaccharide matrix and adhered 
to a cell surface. Formation of biofilms by bacteria and fungus is a defense strategy for protection 
from environment. Microbes secrete extracellular polymeric substances (EPS) that act as a pri-
mary scaffold for attachment to solid substrate [18] and its basic constituents are proteins, poly-
saccharides, nucleic acids with some lipids and humic substances [19]. Three-dimensional study 
of the EPS layer suggested that it forms a gel-like network wherein microbes are embedded and 
it also maintains the attachment of bacteria to the solid substrate [20]. Stability to the 3D structure 
of EPS is rendered by the hydrophobic interactions as well as van der Waals attraction between 
amino acids/peptides and cations such as Ca2+ and Mg2+ [21]. Biofilm formation and its structure 
depend on the environmental conditions to which the bacteria are exposed. When cells are in 
a nutrient stress condition, an increase in EPS secretion occurs, which promotes hydrophobic 
interactions to allow attachment to solid substrate [22]. It has been suggested that the presence 
of a high concentration of EPS negatively affects the diffusion of lipophilic compounds (such as 
sanitizers, antibiotics and hydrocarbons), across the microbial cell surface [23, 24].
Among bacteria, P. aeruginosa is an opportunistic pathogen that causes a number of infections in 
humans. It develops resistance to antibiotics by forming biofilm matrices that comprise polysac-
charide-EPS. It has been noticed that it forms and regulates biofilm via quorum sensing mecha-
nism and therefore most of the researches have focused on disrupting the quorum sensing 
pathway [25]. Similarly, biofilm formation in Staphylococcus epidermidis has also been analyzed 
using different methods such as microtiter plate, congo red agar plate test and via molecular 
detection of the ica locus [26–28]. It was found that production of a slimy substance assisted in 
forming biofilm and was associated with virulence also. The production and formation of bio-
film depend on the media constituents; however, the exact mechanism behind the formation of 
a mature biofilm is still being investigated. However, on the basis of in vitro experimental mod-
els, biofilm formation can be segregated into four different stages: (i) attachment of microbial 
cells to surface, (ii) formation of multi-layer structure via the accumulation and aggregation of 
cells, (iii) maturation of biofilm and (iv) detachment of cells from biofilm into planktonic state 
and initiation of a new biofilm cycle [29, 30]. The initial step of attachment is normally driven 
by hydrophobic, electrostatic and Lifshitze-van der Waals forces, and hence is nonspecific in 
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nature. Additionally, certain specific proteins also assist in binding of the microbes to the sur-
faces [30]. The second step of accumulation is mediated via microbial surface components that 
recognize adhesive matrix molecules and occurs via an active process. This step involves the 
establishment of biofilm on the microbial surface. This process is followed by the maturation 
step. In this step, the characteristic features of the biofilm are formed on basis of specific micro-
bial type. In the final step, where a new phase of invasion is initiated involves the detachment 
and dispersion of the microbes [31, 32]. Figure 1 shows the schematic illustration of the different 
stages in the cycle of biofilm formation and detachment.
P. aeruginosa, Vibrio cholerae and some mycobacterial species are the common human pathogens 
that form biofilms and hence have the possibility of infecting humans. There are several mecha-
nisms via which pathogenic microbes in the biofilm can initiate an infection. The seeding dis-
persal of a large number of pathogenic cells is one of the possible mechanisms that can initiate 
an infection, as the microbes are not sessile in a biofilm and hence can easily detach and initiate 
an infection. Secondly, the virulent phenotypes present in a biofilm can expand their colony 
and initiate infection. This is highly possible as biofilm has a huge heterogeneity in its pheno-
typical constitution [33, 34]. In addition to these, several other mechanisms have been hypoth-
esized that could possibly allow the survival of a pathogenic organism and its transmission. 
For example, the detachment of pathogenic microbes from the biofilm, quorum sensing [35], 
co-aggregation and auto-aggregation [35, 36], modification in biosynthesis of EPS and meta-
bolic pathways and genetic mutations [37] are important issues. However, the complete under-
standing of the mechanism of biofilm formation and virulence requires complete analysis of the 
pathogen’s life cycle, environmental parameters and the different phenotypes.
3. Role of QDs in inhibiting biofilm formation
Biomedical implants are a necessity in modern health care; biofilm formation on these 
implants and devices is a major cause of their failure. Mostly S. epidermidis and S. aureus are 
observed in contaminated biomedical implants and devices [38]. Biofilms formed on implants 
and medical devices are difficult to remove as they are protected by exopolymeric matrix 
secreted by the pathogenic microbe [39]. Although a number of metal and their nanosize 
Figure 1. Schematic illustration of the different stages involved in biofilm formation and detachment.
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forms (silver, copper, gold etc.) have been used as antimicrobial agents, there efficiency is 
diminishing due to MDR. Investigations on the antibacterial and antifungal property of QDs 
have been conducted, which suggests that they can serve as excellent candidates for biomedi-
cal applications because of their solubility and biocompatibility.
Aqueous solubility and compatibility make graphene quantum dots (GQDs) useful in bio-
medicine. GQDs are reported to be biocompatible at cellular levels investigated via WST-1 
assay, LDH production, ROS generation and in vitro and in vivo distribution [40]. GQDs also 





-based band-aids have also been prepared based on the peroxidase-like property 
of these particles. The designed band-aids showed a good anti-disinfectant property. They 
analyzed the effect of formed GQDs on biofilm formation and destruction and observed a 





concentration, respectively. Furthermore, they also observed that GQDs alone also showed 
antibiofilm properties [41]. The studies thus suggested that appropriately designed GQDs 
had the ability to breakdown existing biofilms and simultaneously prevented the formation of 
new ones. Habiba et al. suggested the antimicrobial property of silver-graphene quantum dots 
against P. aeruginosa and S. aureus. They observed a synergistic effect between silver nanopar-
ticles and GQDs with 25 and 50 g/ml of silver-graphene quantum dots inhibiting S. aureus and 
P. aeruginosa growth, respectively. Thus, the potential applicability of Ag-GQDs as fabrication 
and antibacterial coating agents was clearly established [42].
Furthermore, the use of semiconductor QDs will allow visualization of biofilm inhibition due to 
their fluorescent properties. The current methods being used for biofilm analysis are SEM, AFM, 
MRI and Raman spectroscopy that require lengthy and costly procedures apart from sample 
modulation, which sometimes provide partial details of the samples concerned [43, 44]. Other 
than this, conventional fluorescent dyes conjugated with carbohydrate recognition elements 
are used for biofilm analysis via confocal laser microscopy [45]. However, the use of a synthetic 
complex is sometimes toxic to cells thereby preventing in situ analysis. Therefore, QDs can be 
an exceptional solution for this. Moreover, amphiphilic carbon dots (CDs) have been shown to 
penetrate the EPS layer of P. aeruginosa, allowing direct visualization of its architecture, growth 
and how external agents affect its inhibition. The hydrocarbon side chains of CDs dock to the 
EPS network resulting in making the EPS scaffold highly fluorescent [46]. In yet another study, 
QDs with two varied surface chemistry [−COOH and polyethylene glycol (PEG) modified] 
were analyzed for their mobility and distribution in P. aeruginosa PAO1 biofilms. It was inferred 
that the QDs did not penetrate the bacterial cell but did colocalize with EPS matrix of the bio-
film. While surface functionalization and QDs flow rate did not show any distinctive difference, 
analysis of center of density suggested that QDs with –COOH surface groups diffused easily 
compared to PEGlyated QDs. Biofilms treated with PEGlyated QDs had rough polysaccharide 
layers and cell distribution compared to –COOH functionalized QDs. It was thus concluded 
that treatment with nanomaterials can result in varying the structural parameters of biofilm 
[47]. The fluorescent property of QDs would thus allow recognition of biofilm formation at 
different growth stages and environmental conditions. Additionally, spectroscopic analysis can 
also be performed, which would allow better understanding of the phenomenon of binding of 
QDs to EPS. Conjugated QDs have also been used for biofilm imaging analysis. In a study, CdTe 
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QDs tagged with Concanavalin A for labeling the saccharide molecules on the surface of C. albi-
cans was studied. It relied on the ability of Concanavalin A to specifically bind to α-D mannose 
and glucose residues of saccharides. They observed that almost 93% of cells were labeled with 
the modified CdTe particles and were highly specific in activity [48]. Similarly, CdSe/ZnS QDs 
surface capped by 3-mercaptopropionic acid (MPA) and the amino acids (leucine or phenylala-
nine) were also used for labeling the biofilm produced by Shewanella. Amphiphilic core/shell 
CdSe/ZnS QDs were used for labeling the hydrophobic microdomains of biofilm produced by 
Shewanella oneidensis, a Gram-negative bacteria. It was inferred that CdSe/ZnS@dihydrolipoic 
acid-Leu or CdSe/ZnS@dihydrolipoic acid-Phe QDs showed increased hydrophobicity in com-
parison to CdSe-core QDs capped with 3-mercaptopropionic acid (MPA). Thus, the functional 
group on QD surface and the ligand density played an integral role in interaction with biofilm 
matrix. While the hydrophilic MPA-capped QDs were homogeneously associated, DHLA-
Leu and DHLA-Phe QDs were specifically confined assisting in identifying the hydrophobic 
microdomains of biofilm. Hence, appropriate conjugation of surface functional groups can 
significantly dictate their interaction with biofilm [49]. Quite recently, selenium nanoparticles 
have been reported for their tremendous potential in biofilm inhibition in C. albicans. For the 
study, selenium nanoparticles were synthesized via laser ablation method and were used to 
analyze biofilm inhibition. They observed a very good attachment of selenium nanoparticles 
to the Candida surface, which was due to electrostatic attraction between the positively charged 
surface of Candida and negatively charged Se nanoparticles. The particles affect the cellular 
morphology of the fungus by substitution of sulfur groups of amino acids by the Se particles. 
This consequently altered the protein structure and damaged Candida morphology. Size and 
crystallinity of particles had a significant effect on biofilm inhibition [50].
Figure 2 presents the mode of action of quantum dots. The application of QDs as antibiofilm 
agents can inhibit microbial biofilm at two stages. It can act at the initial stage, where its pres-
ence would hinder further attachment of microbial cells to the solid substrate thereby prevent-
ing the progression to mature biofilm stage and EPS secretion. Secondly, QDs can act on the 
matured biofilm, where its penetration into the cells would result in killing of the microbes 
and subsequent dispersion of the formed biofilm.
Figure 2. Schematic illustration showing the possible mode of action of antimicrobial quantum dots on biofilm.
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With this, we envision that QD-based antibiofilm coatings can be promising probes in inves-
tigating biofilm imaging, treatment and their eradication. Furthermore, their broad spectrum 
activity and minimal host toxicity are additional advantages in this regard. Hence, the use of 
semiconductor QDs would not only allow detecting the inhibition process but also favor their 
visible monitoring.
4. Conclusion and future perspective
There is a steady increase in the use of QDs. Despite the several advantages offered by QDs, 
with some improvements, these can emerge as excellent probes for biological applications. 
Focus should be towards improved protocols for functionalizing the surface of QDs simulta-
neously making sure that its properties remain unaltered and secondly, appropriately modi-
fying the surface of QDs so that they do not aggregate in a protein-rich solution or cystol. 
These methods along with the said advantages would assist in utilizing QDs for biological 
and biomedical applications. Furthermore, the QDs can be tagged with antimicrobial drugs or 
drugs can be encapsulated inside the QD core thereby increasing the potency of drugs even at 
low concentration. Synergistic effect of silver nanoparticles with antibiotics such as penicillin 
G, amoxicillin, erythromycin, clindamycin and vancomycin is known. Therefore, studies on 
the synergism between QDs and drug molecules have to be analyzed in detail. This would 
also assist in providing insights into the molecular mechanism of action of QDs and any kind 
of cellular changes occurring in the pathogen upon its interaction with pathogenic microbes. 
Additionally, QDs labeling would allow a high throughput analysis of biofilm inhibition and 
disruptions that will have significant effect in healthcare sector to identify and combat biofilm 
formation and pathogenic infections.
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